Market closed
AADi Bioscience/$AADI
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About AADi Bioscience
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.
Ticker
$AADI
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
53
Website
AADi Bioscience Metrics
BasicAdvanced
$60M
Market cap
-
P/E ratio
-$2.28
EPS
0.37
Beta
-
Dividend rate
Price and volume
Market cap
$60M
Beta
0.37
52-week high
$5.54
52-week low
$1.21
Average daily volume
125K
Financial strength
Current ratio
4.889
Quick ratio
4.374
Long term debt to equity
0.906
Total debt to equity
1.374
Interest coverage (TTM)
-301.35%
Management effectiveness
Return on assets (TTM)
-35.27%
Return on equity (TTM)
-65.95%
Valuation
Price to revenue (TTM)
2.606
Price to book
0.86
Price to tangible book (TTM)
0.86
Price to free cash flow (TTM)
-1.158
Growth
Revenue change (TTM)
7.80%
Earnings per share change (TTM)
-3.08%
3-year revenue growth (CAGR)
20.67%
3-year earnings per share growth (CAGR)
-51.65%
What the Analysts think about AADi Bioscience
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for AADi Bioscience stock.
AADi Bioscience Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
AADi Bioscience Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for AADi Bioscience stock?
AADi Bioscience (AADI) has a market cap of $60M as of December 12, 2024.
What is the P/E ratio for AADi Bioscience stock?
The price to earnings (P/E) ratio for AADi Bioscience (AADI) stock is 0 as of December 12, 2024.
Does AADi Bioscience stock pay dividends?
No, AADi Bioscience (AADI) stock does not pay dividends to its shareholders as of December 12, 2024.
When is the next AADi Bioscience dividend payment date?
AADi Bioscience (AADI) stock does not pay dividends to its shareholders.
What is the beta indicator for AADi Bioscience?
AADi Bioscience (AADI) has a beta rating of 0.37. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.